According to
Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best insurance stocks to buy right now are:
1. Crawford & Co (NYSE:CRD.A)
The Component Grade breakdown for Crawford & Co (NYSE:CRD.A) is: Value: A, Growth: C, Momentum: C, Sentiment: C, Safety: B, Financials: B, and AI: C.
Crawford & Co (NYSE:CRD.A) has a Due Diligence Score of 49, which is 12 points higher than the insurance industry average of 37.
CRD.A passed 18 out of 38 due diligence checks and has strong fundamentals. Crawford & Co has seen its stock return 4.22% over the past year, overperforming other insurance stocks by 14 percentage points.
Crawford & Co has an average 1 year
price target of $14.00, an upside of 31.83% from Crawford & Co's current stock price of $10.62.
Crawford & Co stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Crawford & Co, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Corvel (NASDAQ:CRVL)
Corvel (NASDAQ:CRVL) is the #2 top insurance stock out of 20 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year.
Learn more.
The Component Grade breakdown for Corvel (NASDAQ:CRVL) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: B, Financials: B, and AI: B.
Corvel (NASDAQ:CRVL) has a Due Diligence Score of 43, which is 6 points higher than the insurance industry average of 37.
CRVL passed 14 out of 33 due diligence checks and has strong fundamentals. Corvel has seen its stock lose -15.69% over the past year, underperforming other insurance stocks by -6 percentage points.
3. Marsh & Mclennan Companies (NYSE:MMC)
The Component Grade breakdown for Marsh & Mclennan Companies (NYSE:MMC) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: B, Financials: C, and AI: C.
Marsh & Mclennan Companies (NYSE:MMC) has a Due Diligence Score of 53, which is 16 points higher than the insurance industry average of 37.
MMC passed 19 out of 38 due diligence checks and has strong fundamentals. Marsh & Mclennan Companies has seen its stock lose -11.78% over the past year, underperforming other insurance stocks by -2 percentage points.
Marsh & Mclennan Companies has an average 1 year
price target of $231.00, an upside of 13.83% from Marsh & Mclennan Companies's current stock price of $202.93.
Marsh & Mclennan Companies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 7 analysts covering Marsh & Mclennan Companies, 14.29% have issued a Strong Buy rating, 0% have issued a Buy, 71.43% have issued a hold, while 14.29% have issued a Sell rating, and 0% have issued a Strong Sell.